In this multicenter trial, researchers studied 116 people with idiopathic carpal tunnel syndrome.
The primary outcome was hand function measured by the Carpal Tunnel Syndrome Assessment Questionnaire at 12 months.
Nonsurgical treatment consisted mainly of hand therapy and wrist splinting.
To patients who experienced no improvement, investigators offered treatment with ultrasound.
The researchers report an advantage of surgery at 12 months.
They observed no clinically important adverse events or surgical complications.
A previous randomized controlled trial reported in the Journal of the American Medical Association also suggested greater efficacy of surgery compared with splinting in patients with carpal tunnel syndrome (2002;288:1245–1251).
Investigators led by Annette Gerritsen, PhD, from the Vrije University Medical Center in Amsterdam, the Netherlands, reported a 90% success rate after 18 months in the surgery group vs 75% in the splinting group.
Despite these consistent reports, however, investigators are urging caution.
The superior efficacy of surgery in today’s report and the previous surgery-versus-splinting trial should not necessarily imply that, in patients with moderately severe carpal tunnel syndrome, physicians should always advocate surgery without initial non-surgical treatment.
Nonsurgical Treatment May Still Be Indicated
The results could still justify initial wrist splinting in view of the fact that in both trials, about 60% of nonsurgical patients did not require surgery after 12 months, and the differences in symptom severity score (<0.5 in intention-to-treat analyses) were moderate.
When comparing surgical and nonsurgical treatments for the improvement in carpal tunnel syndrome, speed, degree, and sustainability are important.
Initial nonsurgical treatment has advantages. It is appropriate when symptom duration is short and diagnosis is less certain.
Potential surgical complications are avoided even though serious ones are uncommon.
Surgery can be followed by prolonged work disability.
Persistent pain in the proximal palm 5 years after surgery is reported in 6% of patients.
In addition, although uncommon, recurrence after surgery can be difficult to treat.
Future studies should compare the overall costs of surgical and non-surgical treatments to take into consideration all relevant aspects.
Patient Preference
Still, these 2 trials suggest that hand–wrist exercises and ultrasound do not provide additional benefit beyond that offered by splinting alone.
Patients’ preference is important : faced with the need to wear a splint ach night and during daytime for weeks, some prefer early surgery while others prefer partial recovery to potential surgical risk.
My own conclusion is that patients with carpal tunnel syndrome who do not have satisfactory improvement with nonsurgical treatment should be offered surgery.
My own study (hundreds of surgical patients and many years island follow up) is not supported by any National Institutes of Health.
As a freelance researcher, I disclose no relevant financial relationships.
